Paper39134752
[Cannabis use and cannabis use disorders].
Hoch E and 1 other. Nervenarzt, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. [Cannabis use and cannabis use disorders]. Papers, record 39134752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39134752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Marijuana Abuse | Major topic |
| Humans | |
| Germany | |
| International Classification of Diseases | |
| Adult | |
| Dronabinol | |
| Cross-Sectional Studies | |
| Intersectoral Collaboration | |
| Substance Withdrawal Syndrome | |
| Mental Disorders |
Source PubMed
References167
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35982439 | Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. | BMC Med | 2022 | https://conductscience.org/library/papers/35982439 | PubMed |
| 2 | 25676540 | The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. | Health Technol Assess | 2015 | https://conductscience.org/library/papers/25676540 | PubMed |
| 3 | 33754375 | Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder. | Mov Disord | 2021 | https://conductscience.org/library/papers/33754375 | PubMed |
| 4 | 36767337 | Effects of an App-Based Intervention Program to Reduce Substance Use, Gambling, and Digital Media Use in Adolescents and Young Adults: A Multicenter, Cluster-Randomized Controlled Trial in Vocational Schools in Germany. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/36767337 | PubMed |
| 5 | 21768160 | Adolescent exposure to cannabis as a risk factor for psychiatric disorders. | J Psychopharmacol | 2012 | https://conductscience.org/library/papers/21768160 | PubMed |
| 6 | 30965351 | Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood. | Neuropsychopharmacology | 2019 | https://conductscience.org/library/papers/30965351 | PubMed |
| 7 | 38171626 | Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study. | BMJ Open | 2024 | https://conductscience.org/library/papers/38171626 | PubMed |
| 8 | 26925704 | Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. | Drug Alcohol Depend | 2016 | https://conductscience.org/library/papers/26925704 | PubMed |
| 9 | 33627670 | Cannabis use and cannabis use disorder. | Nat Rev Dis Primers | 2021 | https://conductscience.org/library/papers/33627670 | PubMed |
| 10 | 28513272 | Neuronal DNA Methyltransferases: Epigenetic Mediators between Synaptic Activity and Gene Expression? | Neuroscientist | 2018 | https://conductscience.org/library/papers/28513272 | PubMed |
| 11 | 18978501 | Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. | Clin Neuropharmacol | 2009 | https://conductscience.org/library/papers/18978501 | PubMed |
| 12 | 34021274 | Cannabis and synaptic reprogramming of the developing brain. | Nat Rev Neurosci | 2021 | https://conductscience.org/library/papers/34021274 | PubMed |
| 13 | 21362108 | A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. | Eur J Neurol | 2011 | https://conductscience.org/library/papers/21362108 | PubMed |
| 14 | 16585053 | Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. | Brain | 2006 | https://conductscience.org/library/papers/16585053 | PubMed |
| 15 | 23443718 | Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. | Neuropsychopharmacology | 2013 | https://conductscience.org/library/papers/23443718 | PubMed |
| 16 | 21307846 | Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. | Neuropsychopharmacology | 2011 | https://conductscience.org/library/papers/21307846 | PubMed |
| 17 | 16540272 | Cannabinoids in medicine: A review of their therapeutic potential. | J Ethnopharmacol | 2006 | https://conductscience.org/library/papers/16540272 | PubMed |
| 18 | 15780846 | Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. | Biol Psychiatry | 2005 | https://conductscience.org/library/papers/15780846 | PubMed |
| 19 | 30604051 | An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. | Eur Arch Psychiatry Clin Neurosci | 2019 | https://conductscience.org/library/papers/30604051 | PubMed |
| 20 | 31182351 | Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. | Am J Geriatr Psychiatry | 2019 | https://conductscience.org/library/papers/31182351 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42244019 | Who is at risk? Core mental health symptoms and problematic cannabis use in Germany. | J Cannabis Res | 2026 | https://conductscience.org/library/papers/42244019 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39134752
GET https://conductscience.org/api/papers/v1/39134752/references?page=2